Health Care Facilities

CONCORD HC GP

Meizhongjiaha Hezi's Subsidiary Guangzhou Taihe Tumor Hospital Approved to Join the Guangdong-Hong Kong-Macao Greater Bay Area Pilot Program

AIA Hong Kong and Mainland China Establish Strategic Partnership with China-US Hi-Tech for Proton Therapy

Concord Medical Plans to Increase Holdings in Meizhong Jiaheng

Meizhongjiaheng Successfully Developed Intelligent Health Check Report System

CONCORD HC GP released FY2025 Q1 earnings on August 28, 2025 (BJT) with actual revenue of HKD 107.58 M and EPS of HKD -0.131

CONCORD HC GP released FY2025 Q2 earnings on August 28 During-Market (BJT), actual revenue HKD 109.95 M, actual EPS HKD -0.1313

CONCORD HC GP released FY2025 Semi-Annual earnings on August 28 During-Market (BJT), actual revenue HKD 217.53 M, actual EPS HKD -0.2648

CONCORD HC GP to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Medi-Cancer Care Completes Placement of 48.7236 Million Shares

Medi-C Global Raises HKD 259M Through Placing

Guangzhou Taihe Tumor Hospital Completes First Proton Therapy for Choroidal Melanoma

Meizhongjiaheng Announces Changes in Shanghai Xinhe Partners

Controlling Shareholder of China MediTech Sells 4.46% Shares for 200 Million Yuan

Medi-Care Plus Issuing 18.6 Million New H Shares

Medisonica Releases Proton Therapy Large Language Model

Medison China Harmony places 18.6 million shares for funding

Medi-Cancer Care Launches Proton Therapy Vertical Large Language Model

Yang Jianyu Increased Holdings in China Harmony Healthcare

Concord HC GP released FY2024 Q3 earnings on March 27 (BJT) with actual revenue of 93.84 M HKD and actual EPS of -0.2022 HKD

Concord HC GP released FY2024 9 Months Earnings on March 27 (BJT), with actual revenue of 330.16 M HKD and EPS of -0.4768 HKD

LEGEND UPSTAR

ALMANA

DESIGN CAPITAL

CN SCI-TECH IND

ASIA PIONEER

NUR HOLDINGS

HUICHENG INTL H

ORIENTAL PAY

GLOBAL CORN GP

KINERGY

SAINT BELLA

HYGEIA HEALTH

BAYZED HEALTH

CR MEDICAL

C-MER MEDICAL

CHAOJU EYE CARE

RICI HEALTH

TIANAN MEDICARE

HONLIV HEALTH

YONGHE MEDICAL

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap